Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

INTL MEDICATION

  • FDA Approval
  • May 22, 2023, 11:40 UTC
  • 27
  • 0 comments

FDA approve NALOXONE HYDROCHLORIDE

Comment Full text

SANDOZ

  • FDA Approval
  • May 22, 2023, 11:40 UTC
  • 34
  • 0 comments

FDA approve CLARITHROMYCIN

Comment Full text

SANDOZ

  • FDA Approval
  • May 22, 2023, 11:40 UTC
  • 30
  • 0 comments

FDA approve CLARITHROMYCIN

Comment Full text

BAUSCH AND LOMB INC

  • FDA Approval
  • May 19, 2023, 16:56 UTC
  • 34
  • 0 comments

FDA approve PERFLUOROHEXYLOCTANE

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • May 19, 2023, 16:27 UTC
  • 31
  • 0 comments

FDA approve ADALIMUMAB-ADBM

Comment Full text

PHARMACYCLICS INC

  • FDA Approval
  • May 19, 2023, 11:45 UTC
  • 34
  • 0 comments

FDA approve IBRUTINIB

Comment Full text

AM REGENT

  • FDA Approval
  • May 19, 2023, 11:45 UTC
  • 33
  • 0 comments

FDA approve ISOSULFAN BLUE

Comment Full text

PHARMACYCLICS INC

  • FDA Approval
  • May 19, 2023, 11:45 UTC
  • 31
  • 0 comments

FDA approve IBRUTINIB

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • May 19, 2023, 11:45 UTC
  • 35
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; SPIRONOLACTONE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • May 19, 2023, 11:45 UTC
  • 33
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text
  • Previous
  • 808
  • 809
  • 810
  • 811
  • 812
  • Next

Search

News categories

  • Technical Exchange News(12112)
  • Event(5560)
  • SEC News(254443)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(151524)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin